Bruce Jackson
Stock Analyst at Benchmark Co.
(0.06)
# 4,492
Out of 4,534 analysts
298
Total ratings
37.1%
Success rate
-10.8%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNCY Unicycive Therapeutics | Maintained: Buy | $18 → $13 | $5.48 | +137.23% | 11 | Jul 1, 2026 | |
| MMED MiniMed Group | Maintained: Buy | $20 | $17.39 | +15.01% | 2 | Jun 3, 2026 | |
| HUMA Humacyte | Maintained: Buy | $1 → $2 | $0.70 | +185.71% | 23 | Jun 1, 2026 | |
| BFRI Biofrontera | Maintained: Buy | $3 | $1.06 | +183.02% | 20 | May 19, 2026 | |
| PODD Insulet | Initiated Coverage: Buy | $250 | $163.84 | +52.59% | 1 | May 12, 2026 | |
| DXCM DexCom | Initiated Coverage: Buy | $77 | $74.52 | +3.33% | 1 | May 11, 2026 | |
| TNDM Tandem Diabetes Care | Initiated Coverage: Hold | n/a | $17.55 | - | 1 | May 11, 2026 | |
| NEO NeoGenomics | Upgraded: Buy | $11 | $14.52 | -24.24% | 23 | Apr 29, 2026 | |
| ABT Abbott Laboratories | Maintained: Buy | $145 → $120 | $101.55 | +18.17% | 4 | Apr 17, 2026 | |
| CV CapsoVision | Maintained: Buy | $14 → $10 | $6.88 | +45.35% | 5 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $20 | $2.90 | +589.66% | 11 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $6 | $6.04 | -0.66% | 18 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $187 → $217 | $153.67 | +41.21% | 21 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $5.73 | +440.88% | 18 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.25 → $1 | $0.425 | +135.29% | 6 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.77825 | - | 20 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.13 | - | 14 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $280 → $140 | $0.54 | +25,825.93% | 4 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.59 | n/a | 6 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $3 | $0.8525 | n/a | 6 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.35 → $2 | $1.66 | n/a | 6 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $24 | $0.2074 | n/a | 4 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1 | $0.349899 | n/a | 1 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $0.4 | $0.0001 | n/a | 6 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $960 → $240 | $0.0001 | n/a | 8 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $24.29 | n/a | 15 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $5 | $4.90 | n/a | 13 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.95 | n/a | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $4 | $2.47 | n/a | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.0042 | n/a | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $5.31 | n/a | 3 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $1.18 | n/a | 1 | Jul 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $0.4776 | n/a | 3 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $38 | $40.63 | n/a | 5 | Mar 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.29 | n/a | 5 | Feb 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.12 | n/a | 1 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 → $92 | $19.00 | n/a | 2 | Oct 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $46 | $82.77 | n/a | 2 | Nov 21, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $43.60 | n/a | 2 | Mar 2, 2012 |
Unicycive Therapeutics
Jul 1, 2026
Maintained: Buy
Price Target: $18 → $13
Current: $5.48
Upside: +137.23%
MiniMed Group
Jun 3, 2026
Maintained: Buy
Price Target: $20
Current: $17.39
Upside: +15.01%
Humacyte
Jun 1, 2026
Maintained: Buy
Price Target: $1 → $2
Current: $0.70
Upside: +185.71%
Biofrontera
May 19, 2026
Maintained: Buy
Price Target: $3
Current: $1.06
Upside: +183.02%
Insulet
May 12, 2026
Initiated Coverage: Buy
Price Target: $250
Current: $163.84
Upside: +52.59%
DexCom
May 11, 2026
Initiated Coverage: Buy
Price Target: $77
Current: $74.52
Upside: +3.33%
Tandem Diabetes Care
May 11, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $17.55
Upside: -
NeoGenomics
Apr 29, 2026
Upgraded: Buy
Price Target: $11
Current: $14.52
Upside: -24.24%
Abbott Laboratories
Apr 17, 2026
Maintained: Buy
Price Target: $145 → $120
Current: $101.55
Upside: +18.17%
CapsoVision
Mar 27, 2026
Maintained: Buy
Price Target: $14 → $10
Current: $6.88
Upside: +45.35%
Mar 20, 2026
Maintained: Buy
Price Target: $23 → $20
Current: $2.90
Upside: +589.66%
Mar 16, 2026
Maintained: Buy
Price Target: $20 → $6
Current: $6.04
Upside: -0.66%
Mar 3, 2026
Maintained: Buy
Price Target: $187 → $217
Current: $153.67
Upside: +41.21%
Dec 3, 2025
Reiterated: Buy
Price Target: $31
Current: $5.73
Upside: +440.88%
Nov 20, 2025
Maintained: Buy
Price Target: $1.25 → $1
Current: $0.425
Upside: +135.29%
Nov 7, 2025
Maintained: Hold
Price Target: n/a
Current: $0.77825
Upside: -
Sep 15, 2025
Maintained: Hold
Price Target: n/a
Current: $1.13
Upside: -
Sep 15, 2025
Maintained: Buy
Price Target: $280 → $140
Current: $0.54
Upside: +25,825.93%
Nov 26, 2024
Reiterated: Buy
Price Target: $8
Current: $2.59
Upside: n/a
Oct 11, 2024
Reiterated: Buy
Price Target: $5 → $3
Current: $0.8525
Upside: n/a
Jun 6, 2024
Maintained: Buy
Price Target: $1.35 → $2
Current: $1.66
Upside: n/a
Apr 15, 2024
Maintained: Buy
Price Target: $40 → $24
Current: $0.2074
Upside: n/a
Apr 8, 2024
Initiated Coverage: Buy
Price Target: $1
Current: $0.349899
Upside: n/a
Mar 22, 2024
Maintained: Buy
Price Target: $4 → $0.4
Current: $0.0001
Upside: n/a
Sep 21, 2023
Maintained: Buy
Price Target: $960 → $240
Current: $0.0001
Upside: n/a
Sep 15, 2023
Downgraded: Hold
Price Target: n/a
Current: $24.29
Upside: n/a
Aug 24, 2023
Maintained: Buy
Price Target: $9 → $5
Current: $4.90
Upside: n/a
Jul 21, 2023
Initiated Coverage: Buy
Price Target: $5
Current: $0.95
Upside: n/a
Mar 23, 2023
Maintained: Buy
Price Target: $8 → $4
Current: $2.47
Upside: n/a
Mar 22, 2023
Reiterated: Buy
Price Target: $6
Current: $0.0042
Upside: n/a
Jun 29, 2021
Maintained: Buy
Price Target: $8
Current: $5.31
Upside: n/a
Jul 20, 2018
Initiated Coverage: Buy
Price Target: $27
Current: $1.18
Upside: n/a
Apr 5, 2018
Reiterated: Buy
Price Target: $42
Current: $0.4776
Upside: n/a
Mar 2, 2018
Reiterated: Buy
Price Target: $26 → $38
Current: $40.63
Upside: n/a
Feb 26, 2018
Downgraded: Hold
Price Target: n/a
Current: $4.29
Upside: n/a
Feb 2, 2018
Initiated Coverage: Buy
Price Target: $8
Current: $1.12
Upside: n/a
Oct 28, 2016
Upgraded: Buy
Price Target: $40 → $92
Current: $19.00
Upside: n/a
Nov 21, 2012
Maintained: Hold
Price Target: $46
Current: $82.77
Upside: n/a
Mar 2, 2012
Initiated Coverage: Buy
Price Target: n/a
Current: $43.60
Upside: n/a